.svg)
.svg){kind=small}
.svg){kind=small}
.svg){kind=small}
.svg){kind=small}
.png?width=91&height=92&name=img-container-(1).png)
The Australian Advantage
Cost
Eligible organisations receive a 43.5% cash rebate on trial costs with the Australian Research & Development tax incentive.
.svg)
Speed
Get you trial up and running in 8 weeks with streamlined ethics approvals and no need for an Investigational New Drug application.
Quality
World-class healthcare facilities and renowned experts ensure your data is accepted by international regulatory bodies like the FDA and EMA.
Come and meet us
Our team will be available throughout the Biotech Showcase 2025 event to discuss how we can support your research initiatives. Whether you’re looking to start a new project, save an existing one or simply explore new partnership opportunities, we’re here to help.
Robert Kent
Senior Director, Business Development
Dr David Lloyd
Managing Director
- 30 years of research experience in academia, pharma & CROs
- Advisor to the Australian Government on Clinical Research reforms
- Prominent industry positions, including Co-Chair of the R&D Taskforce
- Appointed to NSW Dept Health Early Phase Expert Oversight Committee
- Previous member of several NHMRC committees overseeing clinical research